Alcresta Therapeutics

United Statesalcresta.com/
acquiredseries-c-plus
series-c-plus
Stage
2014
Founded
3
Investors

About

Alcresta Therapeutics is a commercial-stage company that develops and commercializes innovative enzyme-based products for patients with digestive disorders and rare diseases.

Explore Alcresta Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.